Review: taking Viibryd and Vitamin b12 together


Summary

Drug interactions are reported among people who take Viibryd and Vitamin b12 together. This review analyzes the effectiveness and drug interactions between Viibryd and Vitamin b12. It is created by eHealthMe based on reports of 22 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Viibryd and Vitamin b12 >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Viibryd

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. (latest outcomes from Viibryd 3,528 users)

Vitamin B12

Vitamin b12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. (latest outcomes from Vitamin b12 5,721 users)

On Aug, 22, 2016

22 people who take Viibryd, Vitamin B12 are studied.


Number of reports submitted per year:

Viibryd and Vitamin b12 drug interactions.

Drug effectiveness over time:

Viibryd:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Vitamin B12:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Viibryd:
  • female: 25.0% - (1 of 4 people)
  • male: 50.0% - (1 of 2 people)
Vitamin B12:
  • female: 0.0% - (0 of 4 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Viibryd:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)
Vitamin B12:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

1 - 6 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • memory loss
  • axillary pain
  • heart palpitations
  • heart pounding or racing
  • lymph node pain
  • mastalgia
6 - 12 months:
  • anxiety
  • depression
  • gerd
  • heart palpitations
  • heart pounding or racing
  • anger
2 - 5 years:
  • anger
  • anxiety
  • depression
  • gerd
  • axillary pain
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • lymph node pain
  • mastalgia
  • memory loss
not specified:
  • insomnia
  • diarrhoea
  • fall
  • injection site bruising
  • multiple sclerosis relapse
  • abdominal pain upper
  • adverse event
  • bacterial test positive
  • bipolar disorder
  • bone formation increased

Most common drug interactions by gender *:

female:
  • anxiety
  • anger
  • depression
  • gerd
  • diarrhoea
  • injection site bruising
  • multiple sclerosis relapse
  • bacterial test positive
  • decreased appetite
  • fatigue
male:
  • abdominal pain upper
  • adverse event
  • bipolar disorder
  • bone formation increased
  • cardiac disorder
  • clavicle fracture
  • convulsion
  • depression
  • dissociative identity disorder
  • drug hypersensitivity

Most common drug interactions by age *:

30-39:
  • anger
  • anxiety
  • depression
  • gerd
  • head injury
  • loss of consciousness
  • multiple sclerosis
  • multiple sclerosis relapse
  • pain
  • vein disorder
40-49:
  • axillary pain
  • burning sensation
  • erythema
  • gout
  • heart palpitations
  • heart pounding or racing
  • local swelling
  • lymph node pain
  • mastalgia
  • multiple sclerosis relapse
50-59:
  • insomnia
  • abdominal pain upper
  • adverse event
  • bipolar disorder
  • bone formation increased
  • cardiac disorder
  • clavicle fracture
  • convulsion
  • depression
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Viibryd and Vitamin b12?

Can you answer these questions?

More questions for: Viibryd, Vitamin b12

You may be interested in these reviews

More reviews for: Viibryd, Vitamin b12

On eHealthMe, Viibryd (vilazodone hydrochloride) is often used to treat depression. Vitamin b12 (cobalamin) is often used to treat vitamin b12 deficiency. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.